Human HGF Quantikine ELISA Kit

• Supplier: R&D Systems
• Catalog: DHG00
• Category: ELISA Kit
• Prices: $509.00, $2,440.00, $16,540.00
• Sizes: 1 kit, 1 pack (6 Plates), 1 pack (50 Plates)
• Assay Type: Solid Phase Sandwich ELISA
• Sample Type: Cell Culture Supernates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Citrate Plasma (50 uL)
• Sensitivity: 40 pg/mL
• Range: 125.0 - 8,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Citrate Plasma)
• Format: 96-well strip plate
• Applications: ELISA
• Species Reactivities: Human
• Description: The Quantikine Human HGF Immunoassay is a 4.25 or 4.5 hour solid phase ELISA that is designed to measure HGF levels in cell culture supernates, serum, and plasma
• Gene: HGF

Product images

Human HGF Quantikine ELISA Kit

Human HGF Quantikine ELISA Kit

Human HGF Quantikine ELISA Kit

Product References

Comparison of fibrin glue and Vicryl sutures in conjunctival autografting for - Comparison of fibrin glue and Vicryl sutures in conjunctival autografting for

Wang X, Zhang Y, Zhou L, Wei R, Dong L. Mol Vis. 2017 Apr 19;23:275-285. eCollection 2017.

Preclinical development of a humanized neutralizing antibody targeting HGF. - Preclinical development of a humanized neutralizing antibody targeting HGF.

Kim H, Hong SH, Kim JY, Kim IC, Park YW, Lee SJ, Song SW, Kim JJ, Park G, Kim TM, Kim YH, Park JB, Chung J, Kim IH. Exp Mol Med. 2017 Mar 24;49(3):e309.

Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells - Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells

Lafosse A, Dufeys C, Beauloye C, Horman S, Dufrane D. PLoS One. 2016 Dec 19;11(12):e0168058.

Adipose-derived mesenchymal stem cells from patients with atherosclerotic - Adipose-derived mesenchymal stem cells from patients with atherosclerotic

Saad A, Zhu XY, Herrmann S, Hickson L, Tang H, Dietz AB, van Wijnen AJ, Lerman L, Textor S. Stem Cell Res Ther. 2016 Sep 9;7(1):128.

Neovascularization Potential of Blood Outgrowth Endothelial Cells From Patients - Neovascularization Potential of Blood Outgrowth Endothelial Cells From Patients

Dauwe D, Pelacho B, Wibowo A, Walravens AS, Verdonck K, Gillijns H, Caluwe E, Pokreisz P, van Gastel N, Carmeliet G, Depypere M, Maes F, Vanden Driessche N, Droogne W, Van Cleemput J, Vanhaecke J, Prosper F, Verfaillie C, Luttun A, Janssens S. J Am Heart Assoc. 2016 Apr 18;5(4):e002288.

The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and - The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and

Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T. BMC Cancer. 2015 Feb 25;15:82.

M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of - M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of

Bedkowska GE, Lawicki S, Gacuta E, Pawlowski P, Szmitkowski M. J Ovarian Res. 2015 May 3;8:27.

Multiple regulatory mechanisms of hepatocyte growth factor expression in - Multiple regulatory mechanisms of hepatocyte growth factor expression in

Sakai K, Takeda M, Okamoto I, Nakagawa K, Nishio K. Oncol Lett. 2015 Jan;9(1):405-410. Epub 2014 Nov 11.

Combined targeting of mTOR and c-MET signaling pathways for effective management - Combined targeting of mTOR and c-MET signaling pathways for effective management

Imura Y, Yasui H, Outani H, Wakamatsu T, Hamada K, Nakai T, Yamada S, Myoui A, Araki N, Ueda T, Itoh K, Yoshikawa H, Naka N. Mol Cancer. 2014 Aug 7;13:185.

Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and - Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and

Outani H, Tanaka T, Wakamatsu T, Imura Y, Hamada K, Araki N, Itoh K, Yoshikawa H, Naka N. BMC Cancer. 2014 Jun 19;14:455.